secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001299130-23-000093
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio Q2 revenue $47.6M (+34% YoY); acquires Apton for up to $110M; Onso shipments start
--------------------------------------------------------------------------------

- Q2 revenue $47.6M (+34% YoY); Revio drove record revenue with 45 systems shipped.
- Net loss $69.8M ($0.28 GAAP EPS); non-GAAP net loss $65.6M ($0.26).
- Acquired Apton Biosystems for ~$85M in stock plus up to $25M contingent milestone, valued up to ~$110M.
- Commercial shipments of Onso short-read sequencer commenced; first customer shipment today.
- Cash and investments $829.9M at June 30; issued $441M 1.375% convertible notes due 2030.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913023000093/0001299130-23-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913023000093/pacb-20230802.htm
  HTML page:      https://secwatch.observer/filing/0001299130-23-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer